Psychiatry News and Research

RSS

Psychiatry is the treatment, study and prevention of mental disorders.

She was dancing on the roof and talking gibberish. A special kind of ER helped her.

For decades, hospitals have strained to accommodate patients in psychiatric crisis in emergency rooms.

25 Mar 2019

Antidepressant drugs may not work when neurons are out of shape

elective serotonin reuptake inhibitors are the most commonly prescribed medication for major depressive disorder, yet scientists still do not understand why the treatment does not work in nearly thirty percent of patients with MDD.

22 Mar 2019

Aspiring doctors seek advanced training in addiction medicine

The U.S. Surgeon General’s office estimates that more than 20 million people have a substance use disorder. Meanwhile, the nation’s drug overdose crisis shows no sign of slowing.

22 Mar 2019

Naltrexone implant more effective in reducing relapses in HIV patients with opioid addiction

When patients with HIV who are also battling opioid dependence go without addiction treatment, they are more likely to stop taking their HIV medications than drug-free patients.

22 Mar 2019

Research links participation in team sports to larger hippocampal volumes in children

Adult depression has long been associated with shrinkage of the hippocampus, a brain region that plays an important role in memory and response to stress. Now, new research from Washington University in St. Louis has linked participation in team sports to larger hippocampal volumes in children and less depression in boys ages 9 to 11.

22 Mar 2019

Pitt engineers win $550,000 NSF CAREER award to develop new intervention for people with ASD

Autism was first described by U.S. researchers more than 70 years ago, and today the Centers for Disease Control and Prevention estimates that 1 in 59 children are identified with autism spectrum disorder, affecting more than 3.5 million Americans.

22 Mar 2019

Early life trauma may affect brain structure, contribute to major depressive disorder

Early life trauma may affect the structure of the brain in a way that makes clinical depression more likely to be severe and recurrent, according to a two-year observational study of 110 patients published in The Lancet Psychiatry journal.

22 Mar 2019

Study suggests depression screening when assessing African-Americans for schizophrenia

African-Americans with severe depression are more likely to be misdiagnosed as having schizophrenia, according to a new Rutgers study.

22 Mar 2019

Brain area that only processes spoken, not written words identified

Patients in a new Northwestern Medicine study were able to comprehend words that were written but not said aloud. They could write the names of things they saw but not verbalize them.

22 Mar 2019

TTUHSC El Paso to establish endowed chair in neurology through a major grant

Thanks to a generous $750,000 gift from the Jim and Julie Cardwell Fund and the Cardwell Family Foundation, Texas Tech University Health Sciences Center El Paso (TTUHSC El Paso) is establishing an endowed chair in the department of neurology.

22 Mar 2019

New study offers insight into development of delusions

Delusions are one of the most common symptoms of psychosis, but little is known about what causes them. A new study from researchers at Columbia University and New York State Psychiatric Institute offers insight into the development of delusions, which could lead to better treatments for people with psychosis.

22 Mar 2019

Participation in sports linked with fewer depressive symptoms in children

Participation in team sports is associated with fewer depressive symptoms in children, whereas non-sport activities have no association with symptoms, according to a study in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, published by Elsevier.

21 Mar 2019

WVU researcher discovers higher suicide rate among Medicaid-insured youth

A West Virginia University researcher has discovered the suicide rate of some Medicaid-insured youth--including girls and young women--is higher than those with private insurance.

21 Mar 2019

Butler Hospital receives COBRE grant to enhance research on neuropsychiatric illnesses

Neuropsychiatric illnesses are common and highly impairing conditions that arise from abnormal functioning of the brain.

21 Mar 2019

Study finds link between depression in 20s linked to memory loss in 50s

A new large-scale longitudinal study carried out by University of Sussex psychologists has found a clear link between episodes of depression and anxiety experienced by adults in their twenties, thirties and forties, with a decrease in memory function by the time they are in their fifties.

21 Mar 2019

First postpartum depression drug gets FDA nod

Sage therapeutics’ Zulresso became the first drug approved for postpartum depression by the United States Food and Drugs Administration (FDA). This cause the shares of Sage to rise by over 5 percent on Tuesday this week.

20 Mar 2019

High potency cannabis use linked to psychosis finds study

With more and more states and regions legalizing the use of medical marijuana or cannabis, experts are also looking at the long term effects of marijuana use and its safety. According to a new study published this week in the journal The Lancet Psychiatry, frequent use of marijuana can lead to psychotic episodes.

20 Mar 2019

Study identifies gene variant associated with accelerated cellular aging

It is well known that psychiatric stress is associated with accelerated aging. Now, a new study shows that a gene mutation interacts with multiple types of psychiatric stress including post-traumatic stress disorder (PTSD), pain and sleep disturbances in association with cellular aging.

20 Mar 2019

Roundworm study suggests alternatives for treatment of schizophrenia

A group of Brazilian scientists have long conducted experiments with roundworms to investigate the role of schizophrenia-linked genes in patients' response to antipsychotic drugs. The results obtained thus far point to new ways of understanding resistance to certain classes of medication.

20 Mar 2019

FDA approves first drug for treatment of postpartum depression in adult women

The U.S. Food and Drug Administration today approved Zulresso (brexanolone) injection for intravenous use for the treatment of postpartum depression in adult women. This is the first drug approved by the FDA specifically for PPD.

20 Mar 2019